Alison Lawton

Alison Lawton

Vermögen: - $ am 31.05.2026

63 Jahre
Health Technology
Commercial Services
Consumer Services

Profil

Alison Francis Lawton is currently Director at AgBiome INC since 2021, Director at SwanBio Therapeutics, Inc. since 2021, Independent Director at Dianthus Therapeutics, Inc. since 2023, Director at Bluerock Therapeutics, Inc., and President at Cadena Bio, Inc. Former roles include Chairman & President at Regulatory Affairs Professionals Society, Independent Director at Cubist Pharmaceuticals LLC from 2012 to 2014, Director at CoLucid Pharmaceuticals, Inc. from 2016 to 2017, Independent Director at Spyre Therapeutics, Inc. from 2020 to 2024, Director at Follica, Inc., Director at Massachusetts Medical Device Industry Council, Independent Director at Verastem, Inc. from 2012 to 2020, Director at Kaleido Biosciences, Inc. in 2020, Director at Magenta Therapeutics, Inc. from 2017 to 2018, Independent Director at Magenta Therapeutics, Inc. from 2020 to 2021, Independent Director at X4 Pharmaceuticals, Inc. from 2020 to 2025, Senior Vice President at Genzyme Corp.
from 2011 to 2012, Chief Operating Officer at Aura Biosciences, Inc. from 2015 to 2017, Principal at Parke-Davis & Co. Ltd., General Manager at Genzyme Biosurgery Corp.
from 2012 to 2013, General Manager-Biosurgery at Sanofi, Inc., Chief Operating Officer at OvaScience, Inc. from 2013 to 2014, Head-Genzyme Biosurgery at Sanofi-Aventis, Inc., Chief Operating Officer at X4 Pharmaceuticals, Inc. from 2014 to 2017, Senior Vice President & General Manager at BIOSURGERY S.R.L., and Independent Member-Supervisory Board at ProQR Therapeutics NV from 2014 to 2026.
Education includes undergraduate studies at King's College London.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
18.03.2026 0 ( -.--% ) - $ 31.05.2026
21.05.2026 0 ( -.--% ) - $ 31.05.2026

Aktive Positionen von Alison Lawton

UnternehmenPositionBeginn
DIANTHUS THERAPEUTICS, INC. Vorsitzender 11.09.2023
Präsident -
Direktor/Vorstandsmitglied 04.05.2021
Direktor/Vorstandsmitglied 19.01.2021
Direktor/Vorstandsmitglied -

Ehemalige bekannte Positionen von Alison Lawton

UnternehmenPositionEnde
PROQR THERAPEUTICS N.V. Direktor/Vorstandsmitglied 02.06.2026
X4 PHARMACEUTICALS, INC. Direktor/Vorstandsmitglied 09.06.2025
SPYRE THERAPEUTICS, INC. Direktor/Vorstandsmitglied 01.02.2024
KALEIDO BIOSCIENCES, INC. Vorstandsvorsitzender 16.06.2020
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Alison Lawton im Detail an

Ausbildung von Alison Lawton

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

90

Beziehungen ersten Grades

25

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen25

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Retail Trade

Consumer Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Distribution Services

Health Technology

  1. Börse
  2. Insiders
  3. Alison Lawton